Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Jaarverslag 2023 Download

INVESTEERDERS

Analisten
Degroof Petercam

Laura Roba


H.C. Wainwright

Yi Chen


KBC Securities

Jacob Mekhael


Van Lanschot Kempen

Luísa Morgado

PERSBERICHTEN

INSCHRIJVEN OP ONZE PERSBERICHTEN